Profile data is unavailable for this security.
About the company
OSE Immunotherapeutics SA, formerly Orphan Synergy Europe Pharma SA, is a France-based company, engaged in clinical stage biotechnological sector. It develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The Company's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. It provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.
- Revenue in EUR (TTM)83.44m
- Net income in EUR46.03m
- Incorporated2004
- Employees52.00
- LocationOSE Immunotherapeutics SA22, boulevard Benoni GoullinNANTES 44200FranceFRA
- Phone+33 228291010
- Fax+33 141219107
- Websitehttps://ose-immuno.com/
More ▼